HOME >> BIOLOGY >> NEWS
Simplified Therapy To Prevent TB Proven Effective In Developing Countries

People with HIV in developing countries are far more likely to contract tuberculosis than those without HIV. Although drugs to help prevent TB are available, the normal course of treatment is 12 months, making it difficult for people to comply with treatment especially in countries where access to care is a problem as is monitoring medication. In most developing countries preventive therapy for high risk individuals is not given because of limited resources. Researchers at the Johns Hopkins School of Public have found that a simplified regimen of twice-weekly doses of isoniazid preventive therapy administered for six months or rifampicin and pyrazinamide administered for only two months provided similar overall protection against tuberculosis in HIV-infected, PPD-positive adults.

The study was published in the March 14, 1998 issue of Lancet. Lead author Neal Halsey, MD, professor, International Health, said, "We need to look for innovative and practical ways to prevent TB in developing countries. The current strategy of emphasizing, early diagnosis and treatment of active cases can be improved upon with minimal added resources."

The study looked at 750 participants who were randomly assigned to receive either six months of isoniazid or two months of rifampicin and pyrazinamide given just twice per week. All participants were HIV positive and had a positive purified-protein derivative (PPD) skin test but no signs of active disease. Both regimens proved to be effective in preventing active TB. However, compliance with treatment was higher for those who received the shorter course of treatment. Adherence was strongly associated with duration of treatment. Co-author Richard Chaisson, MD, associate professor, International Health said, "This is great leap forward in finding a way to prevent TB in a lot of people who previously would not have been able to receive appropriate preventive measures."

The results of this
'"/>

Contact: Sharon Rippey
srippey@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
13-Mar-1998


Page: 1 2

Related biology news :

1. 1st International Conference on Cell Therapy for Cardiovascular Disease
2. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
3. Braunschweig Prize 2003 for Molecular Cancer Therapy
4. Alliance for Cancer Gene Therapy announces $1.5 million in national grants to young investigators
5. New research on safety of intracoronary delivery of adenovector reported in cover story of Molecular Therapy
6. Therapy hinders AIDS virus from evolving drug resistance, Hopkins researchers find
7. Invitation To Cover: American Society Of Gene Therapy Meeting
8. Gene Therapy For Pain
9. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy
10. Shock Therapy Exceeds Expectations In Cleaning Up Contaminated Soils
11. Penn Researchers Develop Gene Therapy Technique That Reverses Muscle Membrane Weakness In Muscular Dystrophy Variant

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/19/2019)... ... 2019 , ... Project Lifeline – a community partnership and research ... substance use disorder (SUD) – will take center stage at the upcoming ... program’s effectiveness in preventing and treating opioid abuse in Blair County, Pennsylvania, will receive ...
(Date:11/14/2019)... (PRWEB) , ... November 13, 2019 , ... ... that Robert Peterson, RAC , a regulatory affairs and program management executive ... biopharmaceutical and medical device industries, has joined the firm as an Expert Consultant. ...
(Date:11/12/2019)... ... November 12, 2019 , ... G5, ... improves digital advertising performance up to 25% and reduces cost-per-click by as much ... uses advanced multi-touch attribution (MTA) to predict best advertising outcomes and automatically allocate ...
Breaking Biology News(10 mins):
(Date:10/29/2019)... ... 2019 , ... CaroGen Corporation , a biotechnology company, today announced three ... Jack R Wands, MD, of Brown University , Dr. Steve Projan, PhD, ... MD, PhD, of Wayne State University, formerly a professor at Yale University School of ...
(Date:10/29/2019)... ... October 29, 2019 , ... ... skin*. Using Silios CMS-C multispectral imagers , researchers identified people by the ... identification based on retinal imaging, face recognition, fingerprints and vasculature. , The ...
(Date:10/22/2019)... ANGELES (PRWEB) , ... October 22, 2019 , ... nQ ... Graziadio Business School’s 2019 Most Fundable Companies List which was announced at a showcase ... than $10 million in annual revenue, strong business plans, and impressive near-term growth projections ...
(Date:10/22/2019)... ... October 22, 2019 , ... Enplug , a ... Notification System into its digital signage platform. The collaboration brings one of the ... for users to leverage their existing digital signage networks to quickly disseminate critical ...
Breaking Biology Technology:
Cached News: